vancoavenir 500 mg
bioavenir ltd, israel - vancomycin as hydrochloride - powder for solution for injection - vancomycin as hydrochloride 500 mg/vial - vancomycin - vancomycin hydrochloride is indicated for the treatment of severe or serious infections due to susceptible strains of methicillin - resistant (beta-iactam-resistant) staphylococci.it is also indicated for administration to penicillin-allergic patients as well patients who have failed to respond to or who cannot receive other drugs including cephalosporins or penicillins and for infections due to vancomycin-susceptible organisms that are resistant to other antimicrobial drugs. vancomycin hydrochloride is indicated for first-line therapy when methicillin-resistant staphylococci are suspected but when susceptibility data become available appropriate therapy should be instituted. vancomycin hydrochloride is effective in the treatment of staphylococcal endocarditis as well as in other infections due to staphylococci including lower respiratory tract infections septicemia skin and skin - stucture infection and bone infections. antibiotic therapy is as an adjunct to appropriate surgical measures when staphylococcal infections are purulent and localized. for endocarditis due to streptococcus viridans or streptococcus bovis vancomycin hydrochloride has been shown to be effective in combination with an aminoglycoside.vancomycin hydrochloride has been shown to be effective only in combination with an aminoglycoside for endocarditis due to enterococci (eg enterococcus fecalis). vancomycin hydrochloride has been shown to be effective for the treatment of diphtheroid endocareditis. in early-onset prosthetic valve endocarditis caused by staphylococcus epidermidis or diptheroids vancomycin hydrochloride has been administered successfully in combination with either rifampin an aminoglycoside or combined with both drugs. bacteriologic cultures of specimens should be obtained for isolation and identification of causative organisms and determination of susceptibilities to vancomycin hydrochloride. oral therapy vancomycin hydrochloride injection may be given orally for the treatment of antibiotic-associated pseudomembrannous colitis due to staphylococcus enterocolitis and clostridium difficile. vancomycin hydrochloride is not effective orally when administered for other types of infection.
anti-dandruff- zinc pyrithione shampoo
meeray cosmetics co., ltd. - pyrithione zinc (unii: r953o2rhz5) (pyrithione zinc - unii:r953o2rhz5) - uses: helps prevent recurrence of flaking and itching associated with dandruff. stop use and ask a doctor if condition worsens or does not improve after regular use of this product as directed. condition worsens or does not improve after regular use of this product as directed. helps prevent recurrance of flaking and itching associated with dandruff.
non-submersible device disinfection chamber
device technologies australia pty ltd -
essential d-3 50000 iu capsule
arnet pharmaceutical corp, united states - colecalciferol - capsule - 50000 iu
essential d-3 5000 iu capsule
arnet pharmaceutical corp, united states - colecalciferol - capsule - 5000 iu
essential d-3 10000 iu capsule
arnet pharmaceutical corp, united states - colecalciferol - capsule - 10000 iu
caffeine citrate 10 mg/ml solution for injection
martindale pharma, united kingdom - caffeine citrate - solution for injection - 10 mg/ml
dicoflor 60
ag pharma s.r.l., italy - capsule - 60 mg - lactobacillus rhamnosus gg
spiru-viva
arnet pharmaceutical corp, united states - tablet - 500 mg - spirulina
dicoflor drops
dicofarm spa, italy - oral drops - 5 billion cfu - lactobacillus rhamnosus gg